In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

It is believed, however, that idiopathic Parkinson’s disease is linked to a body’s problems with using a certain protein. Symptoms of Parkinson’s can include tremors, often in the hands or ...

Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

The Phase 1b open-label trial will assess the safety and tolerability of 13.5 mg/kg/day of GT-02287 for three months in patients with GBA1-PD or idiopathic Parkinson’s disease. Secondary endpoints ...

Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...

Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...

The typical idiopathic PD patient presents with asymmetrical ... The Core Assessment Program for Surgical Interventional Therapies in Parkinson's disease recommends that a battery of cognitive ...